Stella Papachristou
Alexandroupoli, ESYE11, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Walking Further with GLP-1RAs: Lessons from the STRIDE Trial.
Journal: The international journal of lower extremity wounds
Published: October 31, 2025
A New, Simple, Pragmatic Clinical Staging of Distal Symmetrical Polyneuropathy in Diabetes: Will it Improve Organisation of Diabetic Foot Care?
Journal: The international journal of lower extremity wounds
Published: August 07, 2025
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes.
Journal: Current vascular pharmacology
Published: May 14, 2025
Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review.
Journal: Advances in therapy
Published: April 29, 2025
Advanced Glycation End Products and Well-Being in Male Subjects with Type 2 Diabetes Mellitus.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: December 22, 2023
Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus.
Journal: Journal of diabetes and its complications
Published: September 14, 2022
Advanced Glycation End Products: Do They Impair Bone Health in Diabetes?
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: August 17, 2022
Correlation Between Skin Advanced Glycation End Products and Cardiac Autonomic Neuropathy Among Subjects with Type 2 Diabetes Mellitus.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Published: April 22, 2022
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?
Journal: Advances in therapy
Published: February 07, 2022
The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?
Journal: Diabetes/metabolism research and reviews
Published: October 09, 2021
Last Updated: 09/26/2026